市場調查報告書
商品編碼
1534248
全球血液透析和腹膜透析市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測Global Hemodialysis and Peritoneal Dialysis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球血液透析和腹膜透析市場需求預計將從 2023 年的 1,302.5 億美元達到近 2,967.3 億美元的市場規模,2024-2032 年研究期間複合年成長率為 9.58%。
血液透析和腹膜透析是用於執行腎衰竭患者的腎臟功能的醫療程序。血液透析涉及透過透析機過濾體外的血液,消除廢物和多餘的液體,然後將純化的血液重新引入體內。腹膜透析使用腹膜(腹腔內的一層膜)作為天然過濾器。清潔液(透析液)會透過導管引入腹膜腔,有助於將血液中的廢物和多餘液體清除到透析液中,然後將其排出體外。血液透析和腹膜透析對於治療末期腎病 (ESRD) 和慢性腎衰竭至關重要,可提供維持生命的治療以維持電解質平衡並清除血液中的毒素。
全球慢性腎臟病和末期腎病(ESRD)盛行率的不斷上升正在推動血液透析和腹膜透析市場的發展。慢性腎臟病 (CKD) 是 ESRD 的主要危險因素,需要定期透析治療來控制腎功能衰退並維持患者健康。透析技術和治療方案的進步提高了血液透析和腹膜透析程序的有效性和安全性。透析膜、透析液成分、血管通路裝置和自動腹膜透析系統的創新可改善治療結果、減少治療時間並提高患者舒適度,進而推動市場成長。此外,醫療保健支出的增加和政府改善腎臟護理服務的措施也支持了市場的擴張。醫療保健系統投資於透析設施、設備升級和患者教育計劃,以滿足日益成長的透析治療需求並改善全球腎臟護理服務的可及性。此外,人口老化以及糖尿病和高血壓發病率的上升(腎臟疾病的主要原因)正在促進血液透析和腹膜透析市場的成長。然而,財務限制和報銷挑戰可能會限制市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球血液透析和腹膜透析市場的每個細分市場進行了包容性評估。血液透析和腹膜透析行業的成長和趨勢為本研究提供了整體方法。
血液透析和腹膜透析市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲血液透析和腹膜透析市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血液透析和腹膜透析市場的主要參與者包括百特、B. Braun SE、Fresenius Medical Care AG、Medtronic、Asahi Kasei Medical Co. Ltd.、Nipro Corp.、DaVita、BD、Nikkiso Co. Ltd.、Cantel Medical 。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Hemodialysis and Peritoneal Dialysis Market is presumed to reach the market size of nearly USD 296.73 Billion by 2032 from USD 130.25 Billion in 2023 with a CAGR of 9.58% under the study period 2024-2032.
Hemodialysis and peritoneal dialysis are medical procedures used to perform the functions of the kidneys in patients with kidney failure. Hemodialysis involves filtering blood outside the body through a dialyzer machine, eliminating waste products and surplus fluids before reintroducing the purified blood into the body. Peritoneal dialysis uses the peritoneum, a membrane lining the abdominal cavity, as a natural filter. A cleansing fluid (dialysate) is introduced into the peritoneal cavity via a catheter, facilitating the removal of waste & excess fluids from the bloodstream into the dialysate, which is then drained out of the body. Both hemodialysis & peritoneal dialysis are essential in managing end-stage renal disease (ESRD) and chronic kidney failure, providing life-sustaining therapy to maintain electrolyte balance and remove toxins from the bloodstream.
The propelling prevalence of chronic kidney disease and end-stage renal disease (ESRD) globally is driving the hemodialysis and peritoneal dialysis market. Chronic kidney disease (CKD) is a major risk factor for ESRD, necessitating regular dialysis therapy to manage kidney function decline and maintain patient health. Advancements in dialysis technology and treatment protocols enhance the efficacy and safety of hemodialysis and peritoneal dialysis procedures. Innovations in dialyzer membranes, dialysate composition, vascular access devices, and automated peritoneal dialysis systems improve treatment outcomes, reduce treatment time, and enhance patient comfort, thereby driving market growth. Moreover, increasing healthcare expenditure and government initiatives to improve renal care services support market expansion. Healthcare systems invest in dialysis facilities, equipment upgrades, and patient education programs to meet the growing demand for dialysis treatments and improve global access to renal care services. Furthermore, the aging population and rising incidence of diabetes & hypertension, leading causes of kidney disease, are contributing to the hemodialysis and peritoneal dialysis market growth. However, financial constraints and reimbursement challenges may restrain market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hemodialysis and Peritoneal Dialysis. The growth and trends of Hemodialysis and Peritoneal Dialysis industry provide a holistic approach to this study.
This section of the Hemodialysis and Peritoneal Dialysis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Hemodialysis and Peritoneal Dialysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemodialysis and Peritoneal Dialysis market include Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co. Ltd., Nipro Corp., DaVita, BD, Nikkiso Co. Ltd., Cantel Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.